Toward an Asymmetric General Access to Azabicyclo[n.2.1]alkanes According to the CN(R,S) Method
摘要:
According to the CN(R,S) strategy, a general method for the synthesis of azabicyclo[n,2,1]alkanes of type 4 was described starting from the 2-cyano-5-oxazolopyrrolidine 5. A Mannich-type cyclization allowed an asymmetric access to potent nicotinic acetylcholine receptor agonists like epibatidine 1, ferruginine 2 and anatoxine-a 3.((C) Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002).
Toward an Asymmetric General Access to Azabicyclo[n.2.1]alkanes According to the CN(R,S) Method
摘要:
According to the CN(R,S) strategy, a general method for the synthesis of azabicyclo[n,2,1]alkanes of type 4 was described starting from the 2-cyano-5-oxazolopyrrolidine 5. A Mannich-type cyclization allowed an asymmetric access to potent nicotinic acetylcholine receptor agonists like epibatidine 1, ferruginine 2 and anatoxine-a 3.((C) Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002).
According to the CN(R,S) strategy, a general method for the synthesis of azabicyclo[n,2,1]alkanes of type 4 was described starting from the 2-cyano-5-oxazolopyrrolidine 5. A Mannich-type cyclization allowed an asymmetric access to potent nicotinic acetylcholine receptor agonists like epibatidine 1, ferruginine 2 and anatoxine-a 3.((C) Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002).